Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Technology Digest.
Press releases published on October 3, 2025
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …
Cartesian Therapeutics Announces New Employment Inducement Grant
FREDERICK, Md., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of an inducement award to …
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced that it has entered into a …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted eight newly-hired employees stock options to purchase an …
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
An expansive biomarker study confirmed OV329 delivered statistically significant inhibition of GABA-AT as measured across multiple metrics OV329 matched or exceeded inhibition demonstrated by therapeutic doses of first-generation GABA-AT inhibitor, …
Swift and Wowza Bring Seamless Streaming to the World’s Most Isolated Locations
DENVER and WEST PERTH, Australia, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Swift, a leader in remote content delivery, has partnered with Wowza, the leader in mission-critical video streaming infrastructure, to bring high-quality streaming to the most bandwidth- …
Angelini Ventures Leads €12 Million Follow-On Investment in Serenis, a Fast-Growing Digital Mental and Physical Health Company
Through its investment, Angelini Ventures aims to promote the expansion and acceleration of Serenis’ digital health and wellbeing services and amplify its leadership in delivering transformative solutions to corporate clients Investment represents a …
Ethereum Startup AgoraLend Opens Fresh Fundraise After Oversubscribed $300,000 Round
DUBAI, United Arab Emirates, Oct. 03, 2025 (GLOBE NEWSWIRE) -- AgoraLend is modernizing traditional lending through decentralized finance (DeFi) on Ethereum, offering mainstream investors clear, transparent credit solutions amid increased market …
Appointment of Marc Le Bozec as Interim CEO
Appointment of Marc Le Bozec as Interim CEO Nantes, October 3, 2025, 8:00 a.m. CET – OSE Immunotherapeutics (ISIN: FR0012127173; Mnemonic: OSE) announces the termination of the position as chief executive officer of Mr. Nicolas Poirier and the appointment …
Nomination de Marc Le Bozec comme Directeur Général par interim
Nomination de Marc Le Bozec comme Directeur Général par interim NANTES, France, 3 octobre 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce la cessation des fonctions de M. Nicolas Poirier en tant que Directeur Général, …
Snail Games 与 Noiz 达成战略合作，于 TwitchCon 提升所发行产品组合的曝光度
加利福尼亚州卡尔弗城, Oct. 03, 2025 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发商与发行商 Snail, Inc. (Nasdaq: SNAL，以下简称 “Snail Games” 或“公司”) 今日宣布，将与连接主播、发行商与开发商以推动真实游戏推广的 Noiz 达成战略合作，并于 TwitchCon 展会重磅推出《蜂巢：异星物语》(Honeycomb: The World Beyond)、《反抗引擎》(Rebel Engine)、《回音：飞艇传说》( …
Santhera gibt die Zulassung von AGAMREE® (Vamorolon) in Kanada zur Behandlung von Duchenne-Muskeldystrophie bekannt
Health Canada hat AGAMREE für die Behandlung von Duchenne-Muskeldystrophie bei Patienten ab 4 Jahren zugelassen Mit dieser Zulassung ist AGAMREE das erste und einzige zugelassene Medikament zur Behandlung von DMD in Kanada Pratteln, Schweiz, 3. Oktober …
Santhera Announces Approval in Canada for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
Health Canada approved AGAMREE for the treatment of Duchenne muscular dystrophy in patients aged 4 years and older This approval makes AGAMREE the first and only approved therapy for DMD in Canada Pratteln, Switzerland, October 3, 2025 – Santhera …
Aduro Clean Technologies präsentiert sich im Oktober auf führenden Branchenveranstaltungen
LONDON, Ontario, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für saubere Technologien, das die Kraft der Chemie nutzt, um minderwertige Rohstoffe wie …
Aduro Clean Technologies participera à des événements majeurs du secteur en octobre
LONDON, Ontario, 03 oct. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (« Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société du secteur des technologies propres qui recycle chimiquement les matières premières de …
ZenaTech anuncia el establecimiento de su sede global de negocio Drone como Servicio (DaaS) en Orlando, aprovechando una industria que crece a más del 36% anual
VANCOUVER, Columbia Británica, Oct. 02, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), un proveedor de soluciones tecnológicas empresariales especializado en drones con inteligencia artificial (IA), Drones como …
Ryoncil® Receives J-Code From Medicare & Medicaid Services (CMS) Facilitating Reimbursement and Broader Patient Access
NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that a specific Healthcare Common Procedure Coding System (HCPCS) J-Code …
NextGen Digital Platforms Inc. Responds to OTC Markets Request on Recent Promotional Activity
Vancouver, B.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, announces …